Cargando…

Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study

Negative and cognitive symptoms are core features of schizophrenia that are correlated in cross-sectional designs. To further explore the relationship between these critical symptom dimensions we use a method for stratifying participants based on level and persistence of negative symptoms from absen...

Descripción completa

Detalles Bibliográficos
Autores principales: Engen, Magnus Johan, Vaskinn, Anja, Melle, Ingrid, Færden, Ann, Lyngstad, Siv Hege, Flaaten, Camilla Bärthel, Widing, Line Hustad, Wold, Kristin Fjelnseth, Åsbø, Gina, Haatveit, Beathe, Simonsen, Carmen, Ueland, Torill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990888/
https://www.ncbi.nlm.nih.gov/pubmed/35401286
http://dx.doi.org/10.3389/fpsyt.2022.841057
_version_ 1784683472848158720
author Engen, Magnus Johan
Vaskinn, Anja
Melle, Ingrid
Færden, Ann
Lyngstad, Siv Hege
Flaaten, Camilla Bärthel
Widing, Line Hustad
Wold, Kristin Fjelnseth
Åsbø, Gina
Haatveit, Beathe
Simonsen, Carmen
Ueland, Torill
author_facet Engen, Magnus Johan
Vaskinn, Anja
Melle, Ingrid
Færden, Ann
Lyngstad, Siv Hege
Flaaten, Camilla Bärthel
Widing, Line Hustad
Wold, Kristin Fjelnseth
Åsbø, Gina
Haatveit, Beathe
Simonsen, Carmen
Ueland, Torill
author_sort Engen, Magnus Johan
collection PubMed
description Negative and cognitive symptoms are core features of schizophrenia that are correlated in cross-sectional designs. To further explore the relationship between these critical symptom dimensions we use a method for stratifying participants based on level and persistence of negative symptoms from absent to sustained levels over a 10-year follow-up period. We investigate associations with cognitive performance and level of global functioning. First-episode psychosis (FEP) participants (n = 102) and healthy controls (n = 116) were assessed at baseline and follow-up. A cognitive battery consisting of 14 tests derived into four domains and a composite score were used in the analyses. FEP participants were stratified based on negative symptom items from the Positive and Negative Syndrome Scale (PANSS-R) into four groups with either no, mild, transitory or sustained symptoms over the 10-year follow-up period. Global functioning was measured with Global Assessment of Functioning Scale-Split version. Multivariate and univariate analyses of variance were used to explore between-group differences in level and course of cognitive performance as global functioning. A multivariate analysis with four cognitive domains as dependent variables, showed significant group differences in performance when including healthy controls and the negative symptom groups. The groups with no and mild negative symptoms outperformed the group with sustained levels of negative symptoms on verbal learning and memory. The group with no negative symptoms also outperformed the group with sustained negative symptoms on the cognitive composite score. Significant improvements on verbal learning and memory, executive functioning and the cognitive composite were detected for the entire sample. No differences in cognitive course were detected. There was a significant improvement in global functioning as measured by the GAF-F over the follow-up period (p < 0.001), without any time x group interactions (p = 0.25). Participants with sustained negative symptoms had a significantly lower level of global functioning at 10-year follow-up with an additional independent effect of the cognitive composite score, compared to all other groups. Individuals with an early illness course characterized by absence of negative symptoms form a group with better cognitive and functional outcomes than the impairments typically associated with schizophrenia. Individuals with sustained levels of negative symptoms on the other hand may require a combined focus on both negative and cognitive symptoms.
format Online
Article
Text
id pubmed-8990888
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89908882022-04-09 Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study Engen, Magnus Johan Vaskinn, Anja Melle, Ingrid Færden, Ann Lyngstad, Siv Hege Flaaten, Camilla Bärthel Widing, Line Hustad Wold, Kristin Fjelnseth Åsbø, Gina Haatveit, Beathe Simonsen, Carmen Ueland, Torill Front Psychiatry Psychiatry Negative and cognitive symptoms are core features of schizophrenia that are correlated in cross-sectional designs. To further explore the relationship between these critical symptom dimensions we use a method for stratifying participants based on level and persistence of negative symptoms from absent to sustained levels over a 10-year follow-up period. We investigate associations with cognitive performance and level of global functioning. First-episode psychosis (FEP) participants (n = 102) and healthy controls (n = 116) were assessed at baseline and follow-up. A cognitive battery consisting of 14 tests derived into four domains and a composite score were used in the analyses. FEP participants were stratified based on negative symptom items from the Positive and Negative Syndrome Scale (PANSS-R) into four groups with either no, mild, transitory or sustained symptoms over the 10-year follow-up period. Global functioning was measured with Global Assessment of Functioning Scale-Split version. Multivariate and univariate analyses of variance were used to explore between-group differences in level and course of cognitive performance as global functioning. A multivariate analysis with four cognitive domains as dependent variables, showed significant group differences in performance when including healthy controls and the negative symptom groups. The groups with no and mild negative symptoms outperformed the group with sustained levels of negative symptoms on verbal learning and memory. The group with no negative symptoms also outperformed the group with sustained negative symptoms on the cognitive composite score. Significant improvements on verbal learning and memory, executive functioning and the cognitive composite were detected for the entire sample. No differences in cognitive course were detected. There was a significant improvement in global functioning as measured by the GAF-F over the follow-up period (p < 0.001), without any time x group interactions (p = 0.25). Participants with sustained negative symptoms had a significantly lower level of global functioning at 10-year follow-up with an additional independent effect of the cognitive composite score, compared to all other groups. Individuals with an early illness course characterized by absence of negative symptoms form a group with better cognitive and functional outcomes than the impairments typically associated with schizophrenia. Individuals with sustained levels of negative symptoms on the other hand may require a combined focus on both negative and cognitive symptoms. Frontiers Media S.A. 2022-03-25 /pmc/articles/PMC8990888/ /pubmed/35401286 http://dx.doi.org/10.3389/fpsyt.2022.841057 Text en Copyright © 2022 Engen, Vaskinn, Melle, Færden, Lyngstad, Flaaten, Widing, Wold, Åsbø, Haatveit, Simonsen and Ueland. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Engen, Magnus Johan
Vaskinn, Anja
Melle, Ingrid
Færden, Ann
Lyngstad, Siv Hege
Flaaten, Camilla Bärthel
Widing, Line Hustad
Wold, Kristin Fjelnseth
Åsbø, Gina
Haatveit, Beathe
Simonsen, Carmen
Ueland, Torill
Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study
title Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study
title_full Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study
title_fullStr Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study
title_full_unstemmed Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study
title_short Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study
title_sort cognitive and global functioning in patients with first-episode psychosis stratified by level of negative symptoms. a 10-year follow-up study
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990888/
https://www.ncbi.nlm.nih.gov/pubmed/35401286
http://dx.doi.org/10.3389/fpsyt.2022.841057
work_keys_str_mv AT engenmagnusjohan cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy
AT vaskinnanja cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy
AT melleingrid cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy
AT færdenann cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy
AT lyngstadsivhege cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy
AT flaatencamillabarthel cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy
AT widinglinehustad cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy
AT woldkristinfjelnseth cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy
AT asbøgina cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy
AT haatveitbeathe cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy
AT simonsencarmen cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy
AT uelandtorill cognitiveandglobalfunctioninginpatientswithfirstepisodepsychosisstratifiedbylevelofnegativesymptomsa10yearfollowupstudy